With the world of Pharma Services moving at a faster and more dynamic pace than ever before, North Point is excited to deliver your monthly “dose” of Pharma Services news, transaction updates, valuation trends, industry themes and more. | | | |
|
EVERSANA, a leading provider of commercial services to the global life sciences industry, announced that it will team up with Amazon Web Services (AWS) to accelerate generative artificial intelligence (AI) use cases across the life sciences industry. Together, the organizations will seek to harness the power of generative AI to help pharmaceutical and life science manufacturers drive efficiencies and business value while improving patient outcomes.To meet the industry's unique needs, EVERSANA and AWS will identify, develop and deploy high-impact solutions across the pharmaceutical commercialization value chain. Together EVERSANA and AWS will “pharmatize” the use of AI across the life sciences industry, offering world-class security and privacy controls and adhering to ethical frameworks for responsible AI development, to ultimately benefit patients, healthcare providers (HCPs) and payers. Initial planned applications include:
- Medical and regulatory review process solutions, to help optimize time-consuming, manual compliance operations.
- Field and patient assistance solutions, like chatbots, to automate mundane tasks, provide more accurate responses and improve user experiences.
- Disease and product education content generation and personalization services, to help life sciences brands improve engagement with and education for both HCPs and patients.
| |
Inizio Engage launches Patient Access Services – an integrated suite of patient support services to enhance access and adherence for specialty therapies. This custom-built, integrated suite of patient support services has been developed to enhance the overall patient experience while encouraging adherence and improving health outcomes in specialty or rare and orphan diseases. This service helps patients, care partners, and healthcare professionals (HCPs) and their staff navigate the inherent complexities encountered during what is often a long journey to diagnosis. Patient Access Services integrates three support functions: treatment navigation, field reimbursement management and clinical education. | |
Nearly a decade after its founding, healthcare marketing agency Nimble Works is launching a new sister shop to serve clients that it sees at the “intersection of clinical and technological innovation.” Known as Vital Works, this offshoot will be overseen by Lisa Reid, one of the founders of Nimble back in 2014, alongside agency veterans and managing partners Kristy Carabello and Sara Zaccheo. The new agency hit the ground running with U.S. medtech giant GE HealthCare, contract research company Clario and sleep apnea device maker SomnoMed, among others, already clients for the agency. “We started Nimble Works almost ten years ago and have been a trusted agency partner to healthcare and medtech clients, including Philips, Novartis, Amneal, DayTwo, and others,” said Reid in a release. “We formed Vital Works as a separate agency to serve companies like GE HealthCare with smart, dedicated, and wholly separate teams, and the utmost respect for our client confidentiality.” Vital Works will also specialize in the “convergence of clinical and technical innovation, offering a unique and holistic perspective on healthcare and health technology,” the agency added in its release. | |
More and more studies are examining how out-of-pocket health care costs such as co-payments and deductibles affect patients. These studies typically find that many patients have difficulty buying the medications they need and paying their household bills. Numerous studies on the topic were presented at the recent annual meeting of the American Society of Clinical Oncology. In one such study of 1108 patients with cancer who received charitable co-pay assistance (CPA), Jeffrey M. Peppercorn, MD, of Massachusetts General Hospital in Boston, and colleagues found that, despite having insurance, 17% and 18% reported delays in starting therapy and skipping medical services, respectively, due to cost. Further, prior to receiving CPA, 66% believed their insurance (mostly Medicare) would shield them from paying high drug costs. Three-quarters of study participants agreed or strongly agreed that doctors should be aware of costs when making decisions. In an article, Daniel D. Joyce, MD, a urologic oncology fellow at Mayo Clinic in Rochester, Minnesota, said financial toxicity, like drug toxicity, should be included in physician patient discussions about treatment options. “Indeed, financial toxicity has been associated with worse quality of life, symptom burden, and even survival, further supporting its inclusion in shared decision-making.” | |
|
Revelation Pharma Completes Two Acquisitions
Revelation acquired Eagle Pharmacy, located in Hoover, Alabama, and Lee Silsby Compounding Pharmacy, located in Beachwood, Ohio. Eagle is a 503B outsourcing compounding pharmacy that serves healthcare facilities, medical offices, patients, and prescribers. Lee Silsby is a 503A compounding pharmacy that serves patients and prescribers in over 45 U.S. states & territories.
| |
|
Thermo Fisher to Acquire CorEvitas for About $913 Million
Thermo Fisher Scientific (TMO.N) said it would acquire healthcare data provider CorEvitas for $912.5 million in cash, as the medical products maker looks to boost its portfolio of services offered to pharmaceutical clients. CorEvitas' data intelligence platform would be added to Thermo Fisher's laboratory products and biopharma services unit, upon completion of the deal.
| |
*Note: Market data as of July 31, 2023 | |
|
580 California Street, Suite 2000
San Francisco, CA 94104
415.358.3500
| |
|
76 Eighth Avenue, 8th floor
New York, NY 10011
337.474.7753
| | | | |
